Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-08 09:40 am Purchase |
2022-12-31 | 13G | Anika Therapeutics, Inc. ANIK |
STATE STREET CORP STT |
908,867 6.220% |
110,299 (+13.81%) |
Filing History |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | Anika Therapeutics, Inc. ANIK |
BLACKROCK INC BLK |
2,526,802 17.300% |
0 (Unchanged) |
Filing History |
| 2023-01-20 09:43 am Purchase |
2022-12-31 | 13G | Anika Therapeutics, Inc. ANIK |
BLACKROCK INC BLK |
2,526,802 17.300% |
168,185 (+7.13%) |
Filing History |
| 2022-10-06 5:58 pm Purchase |
2022-09-20 | 13G | Anika Therapeutics, Inc. ANIK |
Trigran Investments, Inc. | 1,493,245 10.200% |
1,493,245 (New Position) |
Filing History |
| 2022-06-09 4:15 pm Sale |
2022-05-31 | 13G | Anika Therapeutics, Inc. ANIK |
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 627,321 4.310% |
-840,189 (-57.25%) |
Filing History |
| 2022-02-14 12:27 pm Sale |
2021-12-31 | 13G | Anika Therapeutics, Inc. ANIK |
AMERIPRISE FINANCIAL INC AMP |
987,733 6.840% |
-16,375 (-1.63%) |
Filing History |
| 2022-02-11 6:54 pm Sale |
2021-12-31 | 13G | Anika Therapeutics, Inc. ANIK |
Avidity Partners Management LP | 0 0.000% |
-731,000 (Position Closed) |
Filing History |
| 2022-02-11 6:27 pm Sale |
2021-12-31 | 13G | Anika Therapeutics, Inc. ANIK |
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,467,510 10.170% |
-78,753 (-5.09%) |
Filing History |
| 2022-02-10 3:13 pm Sale |
2021-12-31 | 13G | Anika Therapeutics, Inc. ANIK |
Renaissance Technologies LLC | 683,417 4.730% |
-125,700 (-15.54%) |
Filing History |
| 2022-02-10 2:22 pm Sale |
2021-12-31 | 13G | Anika Therapeutics, Inc. ANIK |
STATE STREET CORP STT |
798,568 5.530% |
-22,178 (-2.70%) |
Filing History |
| 2022-02-09 3:24 pm Purchase |
2021-12-31 | 13G | Anika Therapeutics, Inc. ANIK |
The Vanguard Group | 965,913 6.690% |
31,631 (+3.39%) |
Filing History |
| 2022-02-08 3:52 pm Sale |
2022-02-14 | 13G | Anika Therapeutics, Inc. ANIK |
DIMENSIONAL FUND ADVISORS INC | 856,124 5.900% |
-27,992 (-3.17%) |
Filing History |
| 2022-01-27 1:59 pm Unchanged |
2021-12-31 | 13G | Anika Therapeutics, Inc. ANIK |
BLACKROCK INC BLK |
2,358,617 16.300% |
0 (Unchanged) |
Filing History |
| 2022-01-25 6:45 pm Purchase |
2021-12-31 | 13G | Anika Therapeutics, Inc. ANIK |
BLACKROCK INC BLK |
2,358,617 16.300% |
108,327 (+4.81%) |
Filing History |
| 2021-02-16 12:01 pm Purchase |
2020-12-31 | 13G | Anika Therapeutics, Inc. ANIK |
Avidity Partners Management LP | 731,000 5.100% |
731,000 (New Position) |
Filing History |
| 2021-02-12 3:55 pm Sale |
2021-02-16 | 13G | Anika Therapeutics, Inc. ANIK |
DIMENSIONAL FUND ADVISORS INC | 884,116 6.200% |
-117,178 (-11.70%) |
Filing History |
| 2021-02-12 09:45 am Purchase |
2020-12-31 | 13G | Anika Therapeutics, Inc. ANIK |
AMERIPRISE FINANCIAL INC AMP |
1,004,108 7.070% |
1,004,108 (New Position) |
Filing History |
| 2021-02-10 5:49 pm Purchase |
2020-12-31 | 13G | Anika Therapeutics, Inc. ANIK |
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,263 10.880% |
48,154 (+3.21%) |
Filing History |
| 2021-02-10 10:30 am Purchase |
2020-12-31 | 13G | Anika Therapeutics, Inc. ANIK |
The Vanguard Group | 934,282 6.570% |
18,686 (+2.04%) |
Filing History |
| 2021-02-10 09:48 am Purchase |
2020-03-17 | 13G | Anika Therapeutics, Inc. ANIK |
Renaissance Technologies LLC | 809,117 5.690% |
809,117 (New Position) |
Filing History |